Absci Corporation ABSI EBITDA margin

EBITDA margin at other companies

SchrodingerSDGR

-57%-12.2pp

Recursion Pharmaceuticals, Inc.RXRX

-848.9%-51.7pp

Spyre Therapeutics, Inc.SYRE

-17,462.5%-18,885pp

AbCellera Biologics Inc.ABCL

-302.2%-109pp

AnaptysBio, Inc.ANAB

17.8%+9.7pp

Assembly BiosciencesASMB

-116.5%-26.0pp

FAQ

What is Absci Corporation's EBITDA margin?

Absci Corporation (ABSI) reported EBITDA margin of -6,102.2% in Q1 2026.

How has Absci Corporation's EBITDA margin changed year-over-year?

Absci Corporation's EBITDA margin decreased by 193.6% year-over-year, from -2,078.4% to -6,102.2%.

What is the long-term trend for Absci Corporation's EBITDA margin?

Over 5 years (2020 to 2025), Absci Corporation's EBITDA margin has grown at a 72.4% compound annual growth rate (CAGR), from -254.6% to -3,877.7%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.